Comparison between Trust Fintech IPO and Zenith Drugs IPO.
Trust Fintech IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Trust Fintech IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Corporate Capitalventures Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Trust Fintech IPO is up to ₹60.24 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Trust Fintech IPO is ₹101.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Trust Fintech IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹101.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹101.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 59,64,000 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹60.24 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 59,64,000 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹60.24 Cr | up to ₹33.94 Cr |
Trust Fintech IPO opens on Mar 26, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Trust Fintech IPO and Zenith Drugs IPO is Mar 28, 2024, and Feb 22, 2024, respectively.
| Trust Fintech IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Mar 22, 2024 | Feb 16, 2024 |
| Issue Open | Mar 26, 2024 | Feb 19, 2024 |
| Issue Close | Mar 28, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Apr 02, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Apr 03, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Apr 03, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Apr 04, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | May 02, 2024 | Mar 24, 2024 |
| Anchor Lockin End date 2 | Jul 01, 2024 | May 23, 2024 |
Trust Fintech IPO P/E ratio is 44.05, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Trust Fintech IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 93.51 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.85 | 69.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 44.05 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹240.63 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.61% | 35.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 28.54% | 37.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.29 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.51% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Trust Fintech IPO Retail Individual Investors (RII) are offered 20,88,000 shares while in Zenith Drugs IPO retail investors are offered 20,88,000 shares. Qualified Institutional Buyers (QIB) are offered 11,92,800 shares in Trust Fintech IPO and 8,59,200 shares in Zenith Drugs IPO.
| Trust Fintech IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,88,000 shares | 12,88,000 shares |
| Market Maker Reservation | 3,18,000 shares | 8,52,800 shares |
| QIB | 11,92,800 shares | 8,59,200 shares |
| NII | 8,95,200 shares | 6,44,800 shares |
| RII | 20,88,000 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 59,64,000 shares | 42,96,000 shares |
Trust Fintech IPO subscribed 108.63x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Trust Fintech IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 65.38x | 106.72x |
| NII (times) | 244.48x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 75.10x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 108.63x | 179.18x |
